Literature DB >> 11750365

Basiliximab versus ATG/ALG induction in pediatric renal transplants: comparison of herpes virus profile and rejection rates.

P D Acott1, J Lawen, S Lee, J F Crocker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750365     DOI: 10.1016/s0041-1345(01)02354-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.

Authors:  Agnieszka Swiatecka-Urban
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 2.  Basiliximab: a review of its use as induction therapy in renal transplantation.

Authors:  Therese M Chapman; Gillian M Keating
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Longitudinal study on oral shedding of human betaherpesviruses 6 and 7 in renal transplant recipients reveals active replication.

Authors:  Jéssica Vasques Raposo; Dmitry José De Santana Sarmento; Rafaela Barbosa Da Silva Pinto; Amanda Oliveira Lopes; Marina Gallottini; Tânia Regina Tozetto-Mendoza; Paulo Henrique Braz-Silva; Vanessa Salete de Paula
Journal:  J Oral Microbiol       Date:  2020-06-30       Impact factor: 5.474

4.  The role of basiliximab in the evolving renal transplantation immunosuppression protocol.

Authors:  Paola Salis; Chiara Caccamo; Roberto Verzaro; Salvatore Gruttadauria; Mary Artero
Journal:  Biologics       Date:  2008-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.